Evolution of Pancreatic Cancer Management

1. Abstract

Despite the advanced progress made in treating pancreatic cancer including surgical technique refinement and improvement of adjuvant and neo-adjuvant therapies, the pancreatic adenocarcinoma has doubled incidence during the last decades and it remains the most aggressive tumor with low long-term survival rate and poor quality of life.